Enhancing radiotherapy response via intratumoral injection of a TLR9 agonist in autochthonous murine sarcomas
Chang Su(Duke Medical Center), David G. Kirsch(Duke University)
Cited by 5
Related Papers
Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma
|Nature Communications|2017|77
Acute DNA damage activates the tumour suppressor p53 to promote radiation-induced lymphoma
|Nature Communications|2015|63
p53 promotes revival stem cells in the regenerating intestine after severe radiation injury
|Nature Communications|2024|48
Tumor genotype dictates radiosensitization after Atm deletion in primary brainstem glioma models
|Journal of Clinical Investigation|2020|43
Disruption of oncogenic targeting by ISWI via phosphorylation of a prion-like domain
|bioRxiv (Cold Spring Harbor Laboratory)|2020|2